Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: CFN88ESH2J

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Fibronectin receptor alpha inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109622
FDA SRS CFN88ESH2J